Investigating the Efficacy of Sleepgift Blanket on Sleep Quality and Heart Health
1 other identifier
interventional
31
1 country
1
Brief Summary
Exposure to electromagnetic field (EMF) emitted by mobile phones and devices with WIFI is on the rise and so is the EMF effects on sleep quality and well-being of individuals with high exposures to EMF. Some studies have shown poor sleep quality among individuals with long-term occupational exposure to EMF, and some have shown association between EMF long-term exposure and neuropsychiatric disorders including depression. This study aims to investigate a commercially available EMF- blocker blanket, called Sleepgift, that claims helping people to have a better sleep and improved health. We will investigate the Sleepgift efficacy on adults' quality of sleep and their vital signals as a measure of their well-being in a placebo-controlled single- blind cross-over designed study. Participants will sleep in our sleep lab at baseline and then 10 days later with the Sleepgift blanket after using it every night for the past 10 consecutive days. Participants will be given two blankets for each cycle of the study as it is a cross-over designed study: one Sleepgift and one regular blanket; they will not know which one is real or sham. There will be one-month washout period between the two cycles of the cross-over study. We aim to enroll 30 adults for the study. Participants' sleep quality will be measured by the established device called Prodogy; their vital signals will also be measured and monitored through the night. The collected data will be analyzed statistically for any significant effect of the Sleepgift blanket on sleep quality and vital signals such as heart's rhythm and heart rate variability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2022
CompletedFirst Posted
Study publicly available on registry
July 18, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2024
CompletedApril 3, 2025
December 1, 2023
1.8 years
July 12, 2022
March 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sleep quality measure
The change in the value of Odds of the Product (ORP) from baseline line to post-intervention, measured by the Prodigy device which is a combination of the EEG band waves. ORP is only one value output of the device.
Through study completion, 2 years approximately
Secondary Outcomes (1)
heart rate variability
Through study completion, 2 years approximately
Study Arms (2)
Active EMF blanket
ACTIVE COMPARATORparticipants will receive the real EMF blocker blanket
Sham EMF blanket
PLACEBO COMPARATORparticipants will receive the sham EMF blocker blanket
Interventions
Participants for group1 will be provided with real/active sleepgift blanket first for 10 consecutive nights and then cross over.
Participants for group 2 will be provided with sham sleepgift blanket for 10 consecutive nights and then cross over.
Eligibility Criteria
You may qualify if:
- y\<age\<70 years
- Being generally healthy (cognitively and psychologically)
- ability to read, write and speak English fluently.
You may not qualify if:
- Being diagnosed with any neurological, intellectual disability, major depression/anxiety, bipolar disorder, schizophrenia or any other major mood disorder.
- Inability to adequately communicate in English
- Current substance abuse disorder
- Currently participating in another therapeutic study
- Being on a regular pain killer, sleeping or depression pill.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- BB Holisticscollaborator
Study Sites (1)
Riverview Health Center
Winnipeg, Manitoba, R3L 2P4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zahra Moussavi, Ph.D.
University of Manitoba
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- participants receive two similar blankets, while one of them is real and one is sham but they are blind to which one is which.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2022
First Posted
July 18, 2022
Study Start
January 1, 2023
Primary Completion
October 11, 2024
Study Completion
October 11, 2024
Last Updated
April 3, 2025
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After Aug. 2025
When the study is finished, de-identified data could be shared publicly by other researchers.